Autopsy report · NCT05098431
Comparison of Three Approaches of Electrode Placement to Detect Changes in Motor Evoked Potentials During Spine Surgery
Cause of deathSlow enrollment
“Unable to enroll patients.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Na
- Sponsor
- Allina Health System
- Sponsor type
- University, hospital or other
- Conditions
- Intervertebral Disc Degeneration; Intervertebral Disc Displacement; Spinal Stenosis; Spinal Curvatures; Spondylitis; Spondylosis
- Interventions
- Quadriceps and Rectus Femoris MEP Recording
- Participants
- 0
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Systemic Rapamycin (Sirolimus) to Prevent In-Stent Restenosis Following Pulmonary Artery Stent Placement
“Unable to enroll appropriate patients” - Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients
“Unable to enroll patients, no longer at institution.” - Pharmacokinetic Study of Recombinant AT III in Neonates Undergoing ECMO
“Unable to enroll patients into study.” - Discharge Counseling and Medication Therapy Management (MTM) Services After Discharge for Heart Failure Patients
“Unable to enroll and study intended patient population.” - A Randomized, Prospective Clinical Trial of Immediate Flap Closure Versus Wound Care for Management of Late-stage Pressure Ulcers
“We have not been able to enroll patients.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.